Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Revvity (RVTY) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareDiagnostics & ResearchRVTY

Closing price · Nov 19, 2026 $152.44 +0.0% on the day · +65.6% over 12 months 52-week range $82.21 – $165.78
Get RVTY alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling7last 12 months
Reported sales$6.0M16 of 17 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
Latest open-market trade

Sale Anita Gonzales, Vp And Cao sold 84 shares at $155.48 ($13K).

Trade date
Oct 1, 2026
Disclosed to the SEC
Oct 2, 2026
Type
Pre-planned sale, 10b5-1 (code S)

Read the original SEC filing ↗All RVTY insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

RVTY insider transactions (Form 4)

Open-market purchases and sales. 54 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Oct 2SEC Anita GonzalesVp And Cao Sell Plan 847,117 held (−1%) $155.48 $13K -2.0% —
Sep 23SEC Maxwell KrakowiakPlease See Remarks Sell Plan 1,63114,781 held (−10%) $144.53 $236K +5.5% —
Sep 18SEC Tajinder S. VohraPlease See Remarks Sell Plan 7,3306,635 held (−52%) $140.88 $1.0M +8.2% —
Jul 22SEC Anita GonzalesPresident Sell Plan 857,201 held (−1%) $109.48 $9K +39.2% —
Apr 22SEC Anita GonzalesPresident Sell Plan 807,319 held (−1%) $92.80 $7K +64.3% —
Feb 26SEC Miriame VictorPlease See Remarks Sell Plan 1,86218,122 held (−9%) $97.13 $181K +56.9% —
Feb 25SEC Michelle McMurry-HeathDirector Sell 6004,233 held (−12%) $97.26 $58K +56.7% —
Feb 6SEC Prahlad R. SinghPlease See Remarks Sell Plan 12,186132,245 held (−8%) $99.55 $1.2M +53.1% —
Feb 6SEC Prahlad R. SinghPlease See Remarks Sell Plan 7,885124,360 held (−6%) $100.63 $793K +51.5% —
Feb 6SEC Joel S. GoldbergPlease See Remarks Sell Plan 6,42449,540 held (−11%) $99.47 $639K +53.2% —
Feb 6SEC Joel S. GoldbergPlease See Remarks Sell Plan 3,54445,996 held (−7%) $100.50 $356K +51.7% —
Feb 6SEC Prahlad R. SinghPlease See Remarks Sell Plan 3,079121,281 held (−2%) $101.45 $312K +50.3% —
Feb 6SEC Joel S. GoldbergPlease See Remarks Sell Plan 2,21743,779 held (−5%) $101.33 $225K +50.4% —
Feb 6SEC Prahlad R. SinghPlease See Remarks Sell Plan 1,307144,431 held (−1%) $99.02 $129K +53.9% —
Feb 6SEC Prahlad R. SinghPlease See Remarks Sell Plan 1,068120,213 held (−1%) $102.52 $109K +48.7% —
Feb 6SEC Joel S. GoldbergPlease See Remarks Sell Plan 53243,247 held (−1%) $102.52 $55K +48.7% —
Feb 4SEC Tajinder S. VohraPlease See Remarks Sell Plan 5,75610,442 held (−36%) $104.50 $602K +45.9% —
Historical context

Similar past setups: not applicable. RVTY has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with RVTY in the Research Lab

RVTY has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

RVTY closeInsider buyInsider sale
75100125150175DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-01-13EEarnings release filed 2026-02-02EEarnings release filed 2026-05-05EEarnings release filed 2026-08-04Sold $7,424 on 2026-04-20 · Anita GonzalesSold $9,306 on 2026-07-20 · Anita GonzalesSold $13,060 on 2026-10-01 · Anita GonzalesSold $58,356 on 2026-02-23 · Michelle McMurry-HeathSold $180,856 on 2026-02-24 · Miriame VictorSold $235,728 on 2026-09-21 · Maxwell KrakowiakSold $601,502 on 2026-02-02 · Tajinder S. VohraSold $1,032,650 on 2026-09-16 · Tajinder S. VohraSold $3,832,215 on 2026-02-05 · Joel S. Goldberg, Prahlad R. Singh
Bought, 12 months$0
Sold, 12 months$6.0M
Insiders buying0
Insiders selling7

Revvity insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 7 sold $6.0M of RVTY stock on the open market; P/E 71.9 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

RVTY insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $4.7M sold (12 trades)Q1 2026Q2 2026: $7K sold (1 trades)Q2 2026Q3 2026: $1.3M sold (3 trades)Q3 2026Q4 2026: $13K sold (1 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$13K1
Q3 2026—0$1.3M3
Q2 2026—0$7K1
Q1 2026—0$4.7M12

Valuation, profit and volume

P/E (trailing)71.9Sector median 25.0
Market value$16.76BDiagnostics & Research
Profit margin8.2%Revenue growth +1.3%
Volume vs. 50-day0.6×Last 5 sessions

Source: Yahoo Finance, as of Oct 8, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Revvity insiders reported open-market purchases totaling $0, while 7 insiders reported sales totaling $6.0M. 16 of 17 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

RVTY earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Aug 4, 2026 +4.6% Sold $9K -0.2%S&P +1.6% +13.2%
May 5, 2026 -7.9% Sold $7K +14.5%S&P +2.2% -0.7%
Feb 2, 2026 -5.6% None -7.0%S&P -0.4% -4.5%
Jan 13, 2026 +7.4% None +7.3%S&P -0.7% -13.8%
Oct 27, 2025 +8.0% None -2.5%S&P +1.4% +8.5%
Jul 28, 2025 +1.3% None -8.9%S&P -0.3% -5.5%
Apr 28, 2025 +1.4% None +0.4%S&P +0.7% -2.9%
Jan 31, 2025 +6.7% None -2.5%S&P -1.2% -9.7%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

RVTY short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 74% of volume sold short2026-08-27: 69% of volume sold short2026-08-28: 67% of volume sold short2026-08-31: 67% of volume sold short2026-09-01: 71% of volume sold short2026-09-02: 72% of volume sold short2026-09-03: 39% of volume sold short2026-09-04: 43% of volume sold short2026-09-08: 34% of volume sold short2026-09-09: 39% of volume sold short2026-09-10: 46% of volume sold short2026-09-11: 64% of volume sold short2026-09-14: 72% of volume sold short2026-09-15: 55% of volume sold short2026-09-16: 64% of volume sold short2026-09-17: 38% of volume sold short2026-09-18: 46% of volume sold short2026-09-21: 38% of volume sold short2026-09-22: 43% of volume sold short2026-09-23: 42% of volume sold short2026-09-24: 58% of volume sold short2026-09-25: 49% of volume sold short2026-09-28: 56% of volume sold short2026-09-29: 78% of volume sold short2026-09-30: 34% of volume sold short2026-10-01: 53% of volume sold short2026-10-02: 63% of volume sold short2026-10-05: 59% of volume sold short2026-10-06: 40% of volume sold short2026-10-07: 52% of volume sold short2026-10-08: 52% of volume sold short2026-10-09: 59% of volume sold short2026-10-12: 72% of volume sold short2026-10-13: 53% of volume sold short2026-10-14: 44% of volume sold short2026-10-15: 56% of volume sold short2026-10-16: 63% of volume sold short2026-10-19: 55% of volume sold short2026-10-20: 51% of volume sold short2026-10-21: 50% of volume sold short2026-10-22: 35% of volume sold short2026-10-23: 35% of volume sold short2026-10-26: 52% of volume sold short2026-10-27: 27% of volume sold short2026-10-28: 28% of volume sold short2026-10-29: 37% of volume sold short2026-10-30: 22% of volume sold short2026-11-02: 39% of volume sold short2026-11-03: 33% of volume sold short2026-11-04: 43% of volume sold short2026-11-05: 47% of volume sold short2026-11-06: 36% of volume sold short2026-11-09: 57% of volume sold short2026-11-10: 46% of volume sold short2026-11-11: 56% of volume sold short2026-11-12: 58% of volume sold short2026-11-13: 80% of volume sold short2026-11-16: 64% of volume sold short2026-11-17: 46% of volume sold short2026-11-18: 56% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 56%20-day average: 42%Prior 2 months: 53%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Insiders at Revvity

InsiderBoughtSoldLast filingPast buys beat S&PScore
Prahlad R. SinghPlease See Remarks — $2.6M Aug 17, 2026 — —
Tajinder S. VohraPlease See Remarks — $1.6M Sep 18, 2026 — —
Joel S. GoldbergPlease See Remarks — $1.3M Aug 18, 2026 — —
Maxwell KrakowiakPlease See Remarks — $236K Sep 23, 2026 — —
Miriame VictorPlease See Remarks — $181K Feb 26, 2026 — —
Michelle McMurry-HeathDirector — $58K May 11, 2026 — —
Anita GonzalesVp And Cao — $30K Oct 2, 2026 — —
Alexis P. MichasDirector — — Aug 25, 2026 — —
Peter BarrettDirector — — May 11, 2026 — —
Michel VounatsosDirector — — May 11, 2026 1 of 1 —
Samuel R. ChapinDirector — — May 11, 2026 — —
Frank WitneyDirector — — May 11, 2026 1 of 1 —
Michael A. KlobucharDirector — — May 11, 2026 — —
Sophie V. VandebroekDirector — — May 11, 2026 — —
Pascale WitzDirector — — May 11, 2026 — —

Board links: companies that share insiders with RVTY

Directors and executives who filed Form 4s for RVTY and another company in the last 12 months.

See the map →

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

RVTY stock: common questions

Are Revvity insiders buying RVTY stock?

No. No Revvity insider reported an open-market purchase of RVTY in the past 12 months.

Are Revvity insiders selling RVTY stock?

7 insiders reported sales worth $6.0M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is RVTY's P/E ratio?

RVTY trades at about 71.9 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is RVTY's 52-week range?

Over the past year RVTY has traded between $82.21 and $165.78. It last closed at $152.44 on Nov 19, 2026.